» Articles » PMID: 9663605

Differential Characteristics of Two New Tumorigenic Cell Lines of Human Breast Carcinoma Origin

Overview
Journal Int J Cancer
Specialty Oncology
Date 1998 Jul 15
PMID 9663605
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Permanent human tumor cell lines are an important tool for the study of breast cancer. Two new breast cancer cell lines (BrCa-MZ-01 and BrCa-MZ-02) were isolated from a solid tumor and a pleural effusion, respectively. One cell line was established from a medullary carcinoma, the other from a ductal carcinoma. These cells exhibit ultrastructural and immunohistochemical features of epithelial cells of mammary origin. Intermediate filament and cytokeratin typing showed a clear predominance of the simple-epithelial cytokeratins CK 8, CK 18 and CK 19, although the expression was reduced in comparison to the hormone receptor-positive reference cell lines MCF-7 and ZR-75-1. Both cell lines produced slow-growing tumors after subcutaneous (s.c.) transplantation of 1 x 10(7) viable tumor cells into nude mice. The cell line BrCa-MZ-01 expresses the estrogen and progesterone receptor, whereas the cell line BrCa-MZ-02 remains negative. Both cell lines are positive for secretion of platelet-derived growth factor (PDGF) and transforming growth factor-beta (TGF-beta), whereas interleukin-6 (IL-6) is only secreted by the cell line BrCa-MZ-02.

Citing Articles

Poly(ADP-ribose) polymerase 1 (PARP1) overexpression in human breast cancer stem cells and resistance to olaparib.

Gilabert M, Launay S, Ginestier C, Bertucci F, Audebert S, Pophillat M PLoS One. 2014; 9(8):e104302.

PMID: 25144364 PMC: 4140711. DOI: 10.1371/journal.pone.0104302.


Loss, mutation and deregulation of L3MBTL4 in breast cancers.

Addou-Klouche L, Adelaide J, Finetti P, Cervera N, Ferrari A, Bekhouche I Mol Cancer. 2010; 9:213.

PMID: 20698951 PMC: 2933619. DOI: 10.1186/1476-4598-9-213.


CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.

Zabouo G, Imbert A, Jacquemier J, Finetti P, Moreau T, Esterni B Breast Cancer Res. 2009; 11(1):R1.

PMID: 19123925 PMC: 2687703. DOI: 10.1186/bcr2215.


Identification of genes for normalization of real-time RT-PCR data in breast carcinomas.

Lyng M, Laenkholm A, Pallisgaard N, Ditzel H BMC Cancer. 2008; 8:20.

PMID: 18211679 PMC: 2248196. DOI: 10.1186/1471-2407-8-20.


Multicolour-banding fluorescence in situ hybridisation (mbanding-FISH) to identify recurrent chromosomal alterations in breast tumour cell lines.

Letessier A, Mozziconacci M, Murati A, Juriens J, Adelaide J, Birnbaum D Br J Cancer. 2005; 92(2):382-8.

PMID: 15655561 PMC: 2361837. DOI: 10.1038/sj.bjc.6602228.